Outcomes of extensive-stage small cell lung cancer treatment in a real-world clinical setting: a single-center experience
Our results showed that the outcomes of patients with ES-SCLC in real clinical practice are poor. Further studies of real-world treatment outcomes are essential to validate the findings from randomized controlled trials. Ongoing research is needed to explore strategies for improving outcomes and addressing the unmet needs of patients with ES-SCLC.
Authors
- Kristina Galić
- Dragana Karan Križanac
- Emir Begagić (ORCID: https://orcid.org/0000-0002-3988-8911)
- Marija Perić (ORCID: https://orcid.org/0000-0002-2316-6797)
- Krešimir Tomić (ORCID: https://orcid.org/0000-0003-0841-4497)
- Semir Vranić (ORCID: https://orcid.org/0000-0001-9743-7265)
- Sónia Sofia Dantas Calé
- Dragana Miletić
- Gordana Berić Jozić (ORCID: https://orcid.org/0000-0002-4845-8390)
- Inga Marijanović (ORCID: https://orcid.org/0000-0002-8777-9832)
- Eduard Vrdoljak (ORCID: https://orcid.org/0000-0001-8739-5946)
- Maja Pezer Naletilić
- Ema Voloder
- Lejla Abaza
Institutions
- University of Zenica (BA)
- University Clinical Hospital Mostar (BA)
- Qatar University (QA)
- University of Split (HR)
Publication Details
- Journal
- Współczesna Onkologia
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5114/wo.2025.153755
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00